Rare diseases
Investigational molecules
Locations
147 conditions with trials, the busiest first
546 trials across Europe, recruiting first
Study on Improving ECT Response and Reducing Cognitive Side Effects in Depression Patients Using Rivastigmine
The NetherlandsStudy on the Safety and Feasibility of Intravenous Hydromorphone Hydrochloride for Patients with Opioid Dependence
AustriaStudy on Estradiol for Treating Anorexia Nervosa in Adolescent Girls
NorwayA study comparing [18F]SynVesT-1 and [18F]flortaucipir to measure synaptic density and tau protein levels in patients with Alzheimer's disease
The NetherlandsStudy on the Safety and Effectiveness of Pitolisant for Children Aged 6-17 with Narcolepsy, with or without Cataplexy
FranceStudy on the Effects of Sertraline on Anxiety and Depression in Heart Failure Patients with Preserved Ejection Fraction
PolandStudy on the Long-Term Safety of Relacorilant for Patients with Cushing Syndrome
AustriaStudy on Stopping Antidepressants: Comparing Tapering Methods for Patients with Major Depressive Disorder Using Venlafaxine or Paroxetine Hydrochloride
The NetherlandsStudy on Continuing or Reducing Antipsychotic Medication (Haloperidol, Clozapine, Tiapride) for Patients After First Episode of Psychosis
The NetherlandsStudy on Cannabidiol for Reducing Alcohol Consumption in Patients with Alcohol Use Disorder
FranceStudy on the Effects of Cardiodoron Dilution for Patients with Functional Cardiovascular Disorders
GermanyStudy on Lecanemab and Drug Combination for Patients with Early Onset Alzheimer's Disease Due to Genetic Mutation
GermanyThe therapies tested most often in Psychiatric disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
